Meningococcal capsular polysaccharide antigens — Drug Target

All drugs that target Meningococcal capsular polysaccharide antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Conjugate vaccine

Phase 3 pipeline (1)

• Meningococcal Diphtheria Toxoid Vaccine · Sanofi Pasteur, a Sanofi Company · Conjugate vaccine · Immunology / Infectious Disease
  This vaccine stimulates the immune system to produce antibodies against meningococcal polysaccharide antigens conjugated to diphtheria toxoid, providing protection against meningococcal disease.